• Return to Headlines

Neogenomics Inc has the Highest EBITDA Growth in the Life Sciences Tools & Services Industry (NEO, PRAH, BIO, PKI, QGEN)

By Amy Schwartz

Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Neogenomics Inc ranks highest with a EBITDA growth of 84.3%. Following is Pra Health Scien with a EBITDA growth of 75.2%. Bio-Rad Labs-A ranks third highest with a EBITDA growth of 54.5%.

Perkinelmer Inc follows with a EBITDA growth of 47.7%, and Qiagen Nv rounds out the top five with a EBITDA growth of 45.9%.

SmarTrend recommended that its subscribers protect gains by selling shares of Bio-Rad Labs-A on September 18th, 2018 by issuing a Downtrend alert when the shares were trading at $296.58. Since that call, shares of Bio-Rad Labs-A have fallen 18.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest ebitda growth neogenomics inc pra health scien bio-rad labs-a perkinelmer inc qiagen nv

Ticker(s): NEO PRAH BIO PKI QGEN